Insider Buying: Iterum Therapeutics plc (NASDAQ:ITRM) Director Purchases $35,000.00 in Stock

Iterum Therapeutics plc (NASDAQ:ITRM – Get Free Report) Director Michael W. Dunne purchased 25,000 shares of the business’s stock in a transaction dated Friday, December 22nd. The shares were purchased at an average price of $1.40 per share, for a total transaction of $35,000.00. Following the acquisition, the director now owns 113,754 shares of the […]

Related Keywords

Bermuda ,United States ,Ireland ,Michaelw Dunne , ,Goldman Sachs Group Inc ,Renaissance Technologies ,Apollon Wealth Management ,Iterum Therapeutics Company Profile ,Dimensional Fund Advisors ,Nasdaq ,Iterum Therapeutics ,Get Free Report ,Director Michael ,Therapeutics Trading Down ,Sachs Group ,Fund Advisors ,Iterum Therapeutics Daily ,Nasdaq Itrm ,Itrm ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,